Healthcare Triangle EBITDA Margin 2020-2024 | HCTI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Healthcare Triangle (HCTI) over the last 10 years. The current EBITDA margin for Healthcare Triangle as of June 30, 2024 is .
| Healthcare Triangle EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $0.02B | $-0.00B | -13.64% |
| 2024-03-31 | $0.03B | $-0.00B | -10.71% |
| 2023-12-31 | $0.03B | $-0.00B | -11.76% |
| 2023-09-30 | $0.04B | $-0.01B | -21.05% |
| 2023-06-30 | $0.04B | $-0.01B | -19.05% |
| 2023-03-31 | $0.05B | $-0.01B | -17.78% |
| 2022-12-31 | $0.05B | $-0.01B | -15.22% |
| 2022-09-30 | $0.04B | $-0.01B | -13.64% |
| 2022-06-30 | $0.04B | $-0.01B | -17.50% |
| 2022-03-31 | $0.04B | $-0.01B | -13.16% |
| 2021-12-31 | $0.04B | $-0.01B | -14.29% |
| 2021-06-30 | $0.03B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.033B |
| Healthcare Triangle Inc. is a healthcare information technology company focused on solutions in the areas of cloud services, data science, professional and managed services for the healthcare and life sciences industry. Healthcare Triangle Inc. is based in PLEASANTON, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
| Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
| Axonics (AXNX) | United States | $3.603B | 1762.25 |
| IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
| Privia Health (PRVA) | United States | $2.710B | 225.80 |
| Enovis (ENOV) | United States | $2.621B | 17.77 |
| Omnicell (OMCL) | United States | $2.264B | 74.08 |
| Azenta (AZTA) | United States | $2.250B | 112.17 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Schrodinger (SDGR) | United States | $1.620B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
| Phreesia (PHR) | United States | $1.235B | 0.00 |
| Standard BioTools (LAB) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.569B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.278B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
| TruBridge (TBRG) | United States | $0.234B | 67.96 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |